Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the midterm clinical evaluation, biological parameters
and immune reconstitution after Rituximab treatment for Pemphigus.